NexGen Energy (NXE) Updates CAD 500M ATM Program

NexGen Energy Ltd. (NYSE: NXE) announced today that it has updated its at-the-market equity program to offer and sell up to C$500 million of common shares from treasury.

Sales of Common Shares, if any, will be made pursuant to the terms of an equity distribution agreement dated December 11, 2023 (the "Sales Agreement") among the Company, Virtu ITG Canada Corp., as Canadian agent, and Virtu Americas, LLC, as U.S. agent (together, the "Agents"), on the TSX and/or the NYSE, and/or any other marketplace for the Common Shares in Canada or the United States or as otherwise agreed between the Agents and the Company. The volume and timing of sales under the ATM Program, if any, will be determined in the Company's sole discretion, and at the market price prevailing at the time of each sale, and, as a result, sale prices may vary.

The ATM Program is being made pursuant to a prospectus supplement dated December 11, 2023 (the "Prospectus Supplement") to the Company's final short form base shelf prospectus filed in all provinces and territories of Canada dated December 8, 2023 (the "Base Shelf Prospectus"), and pursuant to a prospectus supplement dated December 11, 2023 (the "U.S. Prospectus Supplement") to the Company's U.S. base prospectus (the "U.S. Base Prospectus") included in its registration statement on Form F-10 (the "Registration Statement") (File No. 333-275839) filed with the United States Securities and Exchange Commission on December 8, 2023 (collectively, the Prospectus Supplement, Base Shelf Prospectus, U.S. Prospectus Supplement, the U.S. Base Prospectus and Registration Statement, the "Offering Documents").

As outlined in the Offering Documents, the Company intends to use the net proceeds from the ATM Program, if any, to fund the continued development and further exploration of its mineral properties, and for general corporate purposes.

The ATM Program will be effective until the earlier of the sale of all of the Common Shares issuable pursuant to the ATM Program and January 8, 2026, unless terminated prior to such date by the Company or the Agents. Concurrent with the entering into of the Sales Agreement, the Company's previously announced at-the-market equity distribution agreement dated January 6, 2023 was terminated.

Potential investors should read the Offering Documents, Sales Agreement and other documents the Company has filed for more complete information about the Company and the ATM Program.

You May Also Be Interested In

• Vivos Therapeutics plans rights offering to raise capital
• Humacyte announces underwritten public offering of common stock
• Aduro Clean Technologies prices $15.6 million public offering